Univdatos Whatsapp
Preclinical Imaging Market

Global Preclinical Imaging is Expected to Foresee Significant Growth During the Forecast Period. North America to Witness the Highest Growth

Global Preclinical Imaging Market is expected to grow significantly by 2027 expanding at a reasonable CAGR of around 5% during the forecast period (2021-2027F). Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Researchers use imaging to observe changes, at the organ, tissue, cell, or molecular level, in animals’ response to physiological or environmental changes. 

For a detailed analysis of the preclinical imaging browse through https://univdatos.com/report/preclinical-imaging-market/

The rapidly rising number of rare diseases and orphan diseases increases the demand for the development of novel drugs resulting in the soaring market for pre-clinical research. Furthermore, the involvement of contract research organizations in the pharmaceutical market has a significant effect on the growth of the pre-clinical imaging market. Additionally, the increasing number of drug approvals also compelling the market growth of the pre-clinical trials. For instance, as per CBO, Between 2010 and 2019, the number of new drugs approved for sale increased by 60 percent compared with the previous decade.

For a detailed analysis of the market drivers of preclinical imaging browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=22817

Based on the product, the market is segmented into CT imaging, MRI imaging, PET/SPECT imaging, multi-modal imaging, optical imaging, ultrasound imaging, photoacoustic imaging, reagents, and services. The multi-modal imaging segment is anticipated to witness significant market growth during the forecast period. The multi-modal imaging systems use different techniques for visualization. Furthermore, increasing cases of multiple organ failure and increasing demand for medicines that can treat different drugs are attributed to the significant market share of the segment during the foreseeable future. For instance, as per CDC, High blood sugar can slowly damage the kidneys, and, over time, they can stop filtering blood as well as they should, leading to chronic kidney disease and approximately 1 in 3 adults with diabetes has chronic kidney disease.

Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases, and others. The cardiology segment is predicted to have considerable market growth during the forecast period. This is due to the rising prevalence of cardiovascular disorders and the diseases related to them such as diabetes and hypertension. For instance, as per the CDC, 116 million adults in the United States have hypertension.

For a detailed analysis of the product of preclinical imaging browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=22817

Additionally, the report provides detailed report also provides insights into the preclinical imaging according to the regions such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a significant market for preclinical imaging due to the increasing prevalence of chronic diseases and the rising geriatric population in the region. Furthermore, the higher investment in R&D in the region is the driving factor for the preclinical imaging market. For instance, as per NSB, R&D performed in the United States totaled $606.1 billion in 2018 and $656 billion in 2019. The business sector was the main driver of R&D performance, accounting for about 83% of the growth in R&D from 2010 to 2019.

Bruker Corporation, Siemens AG, General Electric, TriFoil Imaging, PerkinElmer Inc., VisualSonics Inc. (Fujifilm), Mediso Ltd., Agilent Technologies, MILabs B.V., and MR Solutions. are some of the key players operating in the global preclinical imaging market. Several M&As along with partnerships have been undertaken by these players to develop various types of preclinical imaging devices.

Global Preclinical Imaging Market Segmentation

Market Insight, by Product

  • CT Imaging
  • MRI Imaging
  • PET/SPECT Imaging
  • Multi-modal Imaging
  • Optical Imaging
  • Ultrasound Imaging
  • Photoacoustic Imaging
  • Reagents
  • Services

Market Insight, by Application

  • Oncology
  • Neurology
  • Cardiology
  • Infectious diseases
  • Others

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Australia
    • Japan
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Bruker Corporation
  • Siemens AG
  • General Electric
  • TriFoil Imaging
  • PerkinElmer Inc.
  • VisualSonics Inc.
  • Mediso Ltd.
  • Agilent Technologies
  • MILabs B.V.
  • MR Solutions

Leave A Comment

Select Language